Skip to main content
. 2021 Jan 23;9:2050313X21989492. doi: 10.1177/2050313X21989492

Figure 1.

Figure 1.

(a) Assessment of clinical symptoms, SARS-CoV-2 RNA testing, and medication history over the period of illness (days 1–40). (b) Assessment of clinical symptoms, SARS-CoV-2 RNA testing, and medication history over the period of illness (days 41–72).